Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Ketazolam | hsa00030 | Pentose phosphate pathway | 7.84E-03 | 2 | P06744, P37837 | GPI, TALDO1 | More | | Ketazolam | hsa00240 | Pyrimidine metabolism | 2.20E-02 | 3 | P21589, P32320, P04183 | NT5E, CDA, TK1 | More | | Ketazolam | hsa00380 | Tryptophan metabolism | 4.14E-02 | 1 | Q16613 | AANAT | More | | Ketazolam | hsa00500 | Starch and sucrose metabolism | 3.88E-02 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | | Ketazolam | hsa00730 | Thiamine metabolism | 3.79E-02 | 2 | P05186, P24666 | ALPL, ACP1 | More | | Ketazolam | hsa00790 | Folate biosynthesis | 4.74E-02 | 2 | P07101, P42330 | TH, AKR1C3 | More | | Ketazolam | hsa00970 | Aminoacyl-tRNA biosynthesis | 2.12E-02 | 1 | P14868 | DARS | More | | Ketazolam | hsa00983 | Drug metabolism - other enzymes | 1.35E-02 | 3 | P04183, P32320, P05164 | TK1, CDA, MPO | More | | Ketazolam | hsa01200 | Carbon metabolism | 7.69E-03 | 3 | P06744, P37837, P40926 | GPI, TALDO1, MDH2 | More | | Ketazolam | hsa03008 | Ribosome biogenesis in eukaryotes | 4.94E-02 | 2 | P19784, P67870 | CSNK2A2, CSNK2B | More | | Ketazolam | hsa03013 | RNA transport | 8.19E-04 | 7 | Q15287, Q9UBU9, P35658, P63279, P55884, O15371, P20042 | RNPS1, NXF1, NUP214, UBE2I, EIF3B, EIF3D, EIF2S2 | More | | Ketazolam | hsa03040 | Spliceosome | 3.98E-02 | 4 | Q15427, P38159, P61978, P11142 | SF3B4, RBMX, HNRPK, HSPA8 | More | | Ketazolam | hsa03050 | Proteasome | 1.40E-02 | 1 | P55036 | PSMD4 | More | | Ketazolam | hsa03060 | Protein export | 1.43E-02 | 2 | P37108, Q15005 | SRP14, SPCS2 | More | | Ketazolam | hsa03450 | Non-homologous end-joining | 4.21E-02 | 1 | P13010 | XRCC5 | More | | Ketazolam | hsa04012 | ErbB signaling pathway | 3.74E-02 | 3 | P21860, Q13557, O14944 | ERBB3, CAMK2D, EREG | More | | Ketazolam | hsa04014 | Ras signaling pathway | 1.74E-02 | 3 | Q15283, P61586, P62873 | RASA2, RHOA, GNB1 | More | | Ketazolam | hsa04020 | Calcium signaling pathway | 6.50E-04 | 6 | Q96DU7, P45880, Q13557, P21860, P51828, P23634 | ITPKC, VDAC2, CAMK2D, ERBB3, ADCY7, ATP2B4 | More | | Ketazolam | hsa04022 | cGMP-PKG signaling pathway | 4.72E-02 | 4 | Q99941, P23634, P51828, P45880 | CREBL1, ATP2B4, ADCY7, VDAC2 | More | | Ketazolam | hsa04024 | cAMP signaling pathway | 3.37E-02 | 3 | P63092, P26678, P61586 | GNAS, PLN, RHOA | More | | Ketazolam | hsa04060 | Cytokine-cytokine receptor interaction | 3.33E-02 | 8 | P48551, Q9UBD3, P47992, P02775, P09341, P32248, P51684, P01730 | IFNAR2, XCL2, XCL1, PPBP, CXCL1, CCR7, CCR6, CD4 | More | | Ketazolam | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 4.51E-03 | 6 | P51684, P32248, P09341, P02775, P47992, Q9UBD3 | CCR6, CCR7, CXCL1, PPBP, XCL1, XCL2 | More | | Ketazolam | hsa04064 | NF-kappa B signaling pathway | 1.86E-03 | 13 | P10415, Q13489, O00463, Q13546, P01375, Q04759, Q9UDY8, Q13077, Q16548, Q8WV28, P24522, P09341, Q9UNE0 | BCL2, BIRC3, TRAF5, RIPK1, TNF, PRKCQ, MALT1, TRAF1, BCL2A1, BLNK, GADD45A, CXCL1, EDAR | More | | Ketazolam | hsa04071 | Sphingolipid signaling pathway | 2.06E-02 | 7 | Q9H228, P01375, Q13362, Q9BX95, Q16539, P10415, Q9UQC2 | EDG8, TNF, PPP2R5C, SGPP1, MAPK14, BCL2, GAB2 | More | | Ketazolam | hsa04072 | Phospholipase D signaling pathway | 2.75E-02 | 3 | P61586, O14986, P63092 | RHOA, PIP5K1B, GNAS | More | | Ketazolam | hsa04080 | Neuroactive ligand-receptor interaction | 2.54E-02 | 7 | P08311, Q15722, Q9H228, P21462, P21730, Q16581, P35318 | CTSG, LTB4R, EDG8, FPR1, C5AR1, C3AR1, ADM | More | | Ketazolam | hsa04120 | Ubiquitin mediated proteolysis | 6.89E-03 | 5 | Q14145, Q13042, Q13191, Q15751, Q7Z6Z7 | KEAP1, CDC16, CBLB, HERC1, HUWE1 | More | | Ketazolam | hsa04137 | Mitophagy - animal | 2.52E-02 | 2 | P19784, P67870 | CSNK2A2, CSNK2B | More | | Ketazolam | hsa04140 | Autophagy - animal | 2.09E-02 | 4 | Q9NQL2, Q14643, P10415, Q04759 | RRAGD, ITPR1, BCL2, PRKCQ | More | | Ketazolam | hsa04141 | Protein processing in endoplasmic reticulum | 3.64E-02 | 5 | Q99941, O75460, P11142, Q9H3Z4, P07900 | CREBL1, ERN1, HSPA8, DNAJC5, HSP90AA1 | More | | Ketazolam | hsa04211 | Longevity regulating pathway | 1.18E-02 | 3 | Q12778, Q9UEF7, Q96KQ7 | FOXO1, KL, EHMT2 | More | | Ketazolam | hsa04217 | Necroptosis | 2.93E-02 | 3 | P01568, Q13489, Q13546 | IFNA21, BIRC3, RIPK1 | More | | Ketazolam | hsa04261 | Adrenergic signaling in cardiomyocytes | 3.98E-02 | 4 | P51828, Q99941, Q13557, P23634 | ADCY7, CREBL1, CAMK2D, ATP2B4 | More | | Ketazolam | hsa04310 | Wnt signaling pathway | 4.17E-03 | 3 | P61586, P19784, P67870 | RHOA, CSNK2A2, CSNK2B | More | | Ketazolam | hsa04330 | Notch signaling pathway | 4.34E-02 | 2 | Q92542, P46531 | NCSTN, NOTCH1 | More | | Ketazolam | hsa04340 | Hedgehog signaling pathway | 1.43E-02 | 4 | P49841, P22694, Q13635, P10415 | GSK3B, PRKACB, PTCH1, BCL2 | More | | Ketazolam | hsa04510 | Focal adhesion | 4.07E-02 | 3 | O14986, P61586, Q16363 | PIP5K1B, RHOA, LAMA4 | More | | Ketazolam | hsa04520 | Adherens junction | 1.38E-04 | 3 | P19784, P67870, P61586 | CSNK2A2, CSNK2B, RHOA | More | | Ketazolam | hsa04613 | Neutrophil extracellular trap formation | 1.37E-02 | 12 | O60603, P05164, P08246, Q9UM07, Q15080, P20160, P08311, O75015, P21730, P21462, O43315, Q16539 | TLR2, MPO, ELA2, PADI4, NCF4, AZU1, CTSG, FCGR3B, C5AR1, FPR1, AQP9, MAPK14 | More | | Ketazolam | hsa04620 | Toll-like receptor signaling pathway | 4.16E-02 | 2 | Q13546, P01568 | RIPK1, IFNA21 | More | | Ketazolam | hsa04621 | NOD-like receptor signaling pathway | 1.18E-03 | 15 | Q16539, Q14643, P01568, Q13489, P10599, Q9H1Y0, P43490, O00463, P10415, Q13546, P01375, P09341, P59665, P59666, P12838 | MAPK14, ITPR1, IFNA21, BIRC3, TXN, ATG5, PBEF1, TRAF5, BCL2, RIPK1, TNF, CXCL1, DEFA1; DEFA1B, DEFA3, DEFA4 | More | | Ketazolam | hsa04622 | RIG-I-like receptor signaling pathway | 2.39E-02 | 2 | P01568, Q13546 | IFNA21, RIPK1 | More | | Ketazolam | hsa04623 | Cytosolic DNA-sensing pathway | 2.20E-03 | 2 | P01568, Q13546 | IFNA21, RIPK1 | More | | Ketazolam | hsa04657 | IL-17 signaling pathway | 1.28E-02 | 7 | O00463, Q16539, P49841, P09341, P14780, P80188, P01375 | TRAF5, MAPK14, GSK3B, CXCL1, MMP9, LCN2, TNF | More | | Ketazolam | hsa04658 | Th1 and Th2 cell differentiation | 1.70E-04 | 10 | Q04759, P20963, P09693, Q16539, P01730, Q14765, P42226, P23771, Q9UL17, P13765 | PRKCQ, CD247, CD3G, MAPK14, CD4, STAT4, STAT6, GATA3, TBX21, HLA-DOB | More | | Ketazolam | hsa04659 | Th17 cell differentiation | 4.05E-03 | 9 | Q04759, Q16539, P01730, P42226, P13765, Q9UL17, P23771, P09693, P20963 | PRKCQ, MAPK14, CD4, STAT6, HLA-DOB, TBX21, GATA3, CD3G, CD247 | More | | Ketazolam | hsa04660 | T cell receptor signaling pathway | 1.07E-02 | 9 | P01375, Q04759, O95267, Q08881, P20963, P09693, P01732, Q16539, P49841 | TNF, PRKCQ, RASGRP1, ITK, CD247, CD3G, CD8A, MAPK14, GSK3B | More | | Ketazolam | hsa04668 | TNF signaling pathway | 4.74E-02 | 3 | Q99941, P01584, O95429 | CREBL1, IL1B, BAG4 | More | | Ketazolam | hsa04710 | Circadian rhythm | 2.43E-02 | 1 | O15516 | CLOCK | More | | Ketazolam | hsa04713 | Circadian entrainment | 4.94E-02 | 2 | P62873, P63092 | GNB1, GNAS | More | | Ketazolam | hsa04723 | Retrograde endocannabinoid signaling | 3.13E-03 | 2 | P48169, P62873 | GABRA4, GNB1 | More | | Ketazolam | hsa04724 | Glutamatergic synapse | 3.65E-02 | 2 | P63092, P62873 | GNAS, GNB1 | More | | Ketazolam | hsa04726 | Serotonergic synapse | 2.52E-02 | 2 | P63092, P62873 | GNAS, GNB1 | More | | Ketazolam | hsa04727 | GABAergic synapse | 3.69E-02 | 2 | P62873, P48169 | GNB1, GABRA4 | More | | Ketazolam | hsa04742 | Taste transduction | 4.80E-02 | 1 | P48169 | GABRA4 | More | | Ketazolam | hsa04750 | Inflammatory mediator regulation of TRP channels | 3.74E-02 | 3 | P01584, P51828, Q13557 | IL1B, ADCY7, CAMK2D | More | | Ketazolam | hsa04911 | Insulin secretion | 1.48E-02 | 3 | P51828, Q99941, Q13557 | ADCY7, CREBL1, CAMK2D | More | | Ketazolam | hsa04915 | Estrogen signaling pathway | 4.72E-02 | 4 | Q99941, P51828, P07900, P11142 | CREBL1, ADCY7, HSP90AA1, HSPA8 | More | | Ketazolam | hsa04925 | Aldosterone synthesis and secretion | 5.19E-03 | 4 | Q99941, P51828, Q13557, P23634 | CREBL1, ADCY7, CAMK2D, ATP2B4 | More | | Ketazolam | hsa04934 | Cushing syndrome | 3.48E-03 | 4 | Q99941, P51828, O15169, Q13557 | CREBL1, ADCY7, AXIN1, CAMK2D | More | | Ketazolam | hsa04940 | Type I diabetes mellitus | 1.87E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Ketazolam | hsa04966 | Collecting duct acid secretion | 2.52E-02 | 2 | P02730, Q9Y666 | SLC4A1, SLC12A7 | More | | Ketazolam | hsa04971 | Gastric acid secretion | 1.48E-02 | 3 | P51828, P15311, Q13557 | ADCY7, VIL2, CAMK2D | More | | Ketazolam | hsa04972 | Pancreatic secretion | 3.65E-02 | 2 | P63092, P61586 | GNAS, RHOA | More | | Ketazolam | hsa04975 | Fat digestion and absorption | 2.80E-02 | 1 | O14494 | PLPP1 | More | | Ketazolam | hsa05010 | Alzheimer disease | 2.07E-02 | 7 | Q92542, P05496, P12074, O75460, P01584, O15169, P45880 | NCSTN, ATP5G1, COX6A1, ERN1, IL1B, AXIN1, VDAC2 | More | | Ketazolam | hsa05020 | Prion disease | 1.81E-02 | 7 | P01584, P46531, P11142, P05496, P12074, P45880, Q99941 | IL1B, NOTCH1, HSPA8, ATP5G1, COX6A1, VDAC2, CREBL1 | More | | Ketazolam | hsa05032 | Morphine addiction | 3.02E-06 | 5 | P62873, P48169, P78334, P63092, P32298 | GNB1, GABRA4, GABRE, GNAS, GRK4 | More | | Ketazolam | hsa05033 | Nicotine addiction | 2.43E-02 | 1 | P48169 | GABRA4 | More | | Ketazolam | hsa05132 | Salmonella infection | 9.85E-03 | 4 | Q13546, Q13489, O60282, P68371 | RIPK1, BIRC3, KIF5C, TUBB2C | More | | Ketazolam | hsa05142 | Chagas disease | 2.26E-02 | 3 | P01375, P30679, P48023 | TNF, GNA15, FASLG | More | | Ketazolam | hsa05143 | African trypanosomiasis | 2.72E-02 | 2 | P01375, P48023 | TNF, FASLG | More | | Ketazolam | hsa05150 | Staphylococcus aureus infection | 3.62E-03 | 8 | P21730, P21462, O75015, P13765, Q16581, P59665, P59666, P12838 | C5AR1, FPR1, FCGR3B, HLA-DOB, C3AR1, DEFA1; DEFA1B, DEFA3, DEFA4 | More | | Ketazolam | hsa05163 | Human cytomegalovirus infection | 2.09E-02 | 4 | P62873, P61586, P63092, P61769 | GNB1, RHOA, GNAS, B2M | More | | Ketazolam | hsa05169 | Epstein-Barr virus infection | 5.93E-03 | 14 | P13765, P04637, O00463, P16070, P10415, Q16539, P24522, Q8WV28, P48551, P01375, O60603, P29728, P09693, P20963 | HLA-DOB, TP53, TRAF5, CD44, BCL2, MAPK14, GADD45A, BLNK, IFNAR2, TNF, TLR2, OAS2, CD3G, CD247 | More | | Ketazolam | hsa05171 | Coronavirus disease - COVID-19 | 4.47E-02 | 2 | Q9UHA3, O14786 | RSL24D1, NRP1 | More | | Ketazolam | hsa05202 | Transcriptional misregulation in cancer | 8.07E-04 | 14 | Q15532, P14780, P27930, Q16548, Q13077, Q15652, O15550, P35226, P05164, P12838, P08246, Q9C0K0, P41182, P24522 | SS18, MMP9, IL1R2, BCL2A1, TRAF1, JMJD1C, UTX, BMI1, MPO, DEFA4, ELA2, BCL11B, BCL6, GADD45A | More | | Ketazolam | hsa05206 | MicroRNAs in cancer | 2.97E-03 | 6 | P15311, P21860, P61978, P46531, P63279, P22105 | VIL2, ERBB3, HNRPK, NOTCH1, UBE2I, TNXB | More | | Ketazolam | hsa05213 | Endometrial cancer | 4.59E-02 | 3 | Q9UJU2, P04637, P24522 | LEF1, TP53, GADD45A | More | | Ketazolam | hsa05214 | Glioma | 4.59E-02 | 3 | Q16566, P04637, P24522 | CAMK4, TP53, GADD45A | More | | Ketazolam | hsa05216 | Thyroid cancer | 1.35E-02 | 3 | Q9UJU2, P04637, P24522 | LEF1, TP53, GADD45A | More | | Ketazolam | hsa05217 | Basal cell carcinoma | 1.80E-04 | 5 | Q13635, P49841, Q9UJU2, P04637, P24522 | PTCH1, GSK3B, LEF1, TP53, GADD45A | More | | Ketazolam | hsa05226 | Gastric cancer | 3.41E-02 | 5 | Q9UJU2, P04637, P24522, P14923, P10415 | LEF1, TP53, GADD45A, JUP, BCL2 | More | | Ketazolam | hsa05321 | Inflammatory bowel disease | 7.62E-04 | 7 | O60603, P01375, P13765, Q14765, Q9UL17, P42226, P23771 | TLR2, TNF, HLA-DOB, STAT4, TBX21, STAT6, GATA3 | More | | Ketazolam | hsa05330 | Allograft rejection | 2.72E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Ketazolam | hsa05332 | Graft-versus-host disease | 3.70E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Ketazolam | hsa05414 | Dilated cardiomyopathy | 2.68E-02 | 2 | P09493, P26678 | TPM1, PLN | More | | |